Background {#Sec1}
==========

Atrial fibrillation (AF) is the most common arrhythmia after cardiac surgery \[[@CR1]\]. Many risk factors exist for development of post-operative AF (POAF) \[[@CR2]--[@CR5]\]. POAF is the consequence of multiple re-entry wavelets resulting from the "dispersion of atrial refractoriness" (non-uniformity of the distribution of local atrial refractory periods). Dispersion of atrial refractoriness requires an atrial structural substrate. It might be the consequence of advanced age, hypertension, diabetes, obesity, left atrial enlargement, and left ventricular hypertrophy. Operative and post-operative factors such as atrial ischemia and surgical atrial injury might also contribute to the development of the structural substrate. Inflammation, oxidative stress, and genetic factors also seem to play an important role. Once these conditions are present, a triggering factor such as an atrial premature contraction, electrolyte imbalance, and/or enhanced adrenergic or vagal stimulation will initiate POAF \[[@CR6]\]. Both experimental and clinical studies have provided strong evidence that atrial ischemia is the primary stimulus that triggers the development of POAF in patients with atrial "dispersion of refractoriness" \[[@CR6]\]. Since its incidence peaks at post-operative day 2 or 3, inflammatory mechanisms, both systemic and local, may also play an important role in the development of POAF \[[@CR2]\].

Off-pump technique of coronary artery bypass grafting (OPCAB) is believed to elicit less systemic inflammation than on-pump surgery because of reduced cytokine responses and less myocardial injury. OPCAB also allows avoidance of ischemia/reperfusion injury and reduces the oxidative stress. Ascione et al. \[[@CR7]\] reported that the incidence of POAF after CABG was decreased, from 45% in patients operated under cardiopulmonary bypass (CPB) to 11% in those operated without CPB. Another study \[[@CR8]\] documented reduction in POAF, from 28% in hearts protected with cardioplegic arrest to 9% in those operated on using intermittent ischemia. Both these studies point to inadequate atrial protection using cardioplegic arrest as the trigger for developing POAF.

The incidence of POAF also varies depending upon the race. In a study of Indian patients undergoing CABG under CPB and cardioplegic arrest, Borde et al. \[[@CR9]\] found the incidence of POAF to be 13%, much lower than reported in western literature. In one trans-continental study conducted in 70 centers \[[@CR10]\], the incidence of POAF after CABG surgery was 32.3%. This incidence was similar among patients in the USA (33.7%), Canada (36.6%), Europe (34.0%), the UK (31.6%), and the Middle East (41.6%), but the incidence was lower in South America (17.4%) and Asia (15.7%).

In the past, POAF was considered as a benign arrhythmia \[[@CR11]\]; multiple studies \[[@CR12]--[@CR15]\] have shown that POAF increases the post-operative morbidity and mortality in the short term and has long-term consequences as well. After adjusting for the influence of baseline patient operative features, surgeon and hospital variability, and operative era, LaPar and associates found that POAF was associated with a 1.8-fold to twofold increase in the odds of mortality for isolated CABG and aortic valve procedures. They also found that patients suffering POAF had twofold to fourfold increase in stroke, greater hospital resource utilization, and increased costs \[[@CR16]\].

However, there is paucity of data in literature about its effect in off-pump CABG (OPCAB) patients from the Indian subcontinent, where more than 60% of patients undergo OPCAB \[[@CR17]\]. Hence, there is a pressing need to evaluate the incidence, risk factors, and effect of POAF in OPCAB patients from India.

Objective {#Sec2}
=========

The aims of our study wereTo determine the incidence of POAF after OPCAB surgery in Indian patientsTo find the risk factors for development of POAF after OPCAB surgery andTo answer the question whether POAF increases the mortality and morbidity after OPCAB surgery.

Materials and methods {#Sec3}
=====================

From January 2015 to December 2016, consecutive patients who underwent OPCAB (748 patients) were enrolled in the study. Patients were divided into two groups based on their post-operative rhythm status: AF (*n* = 127; 16.7%) and NSR (*n* = 621; 83.3%). Pre-operative variables included in the study were age, gender, urgency of surgery, diabetes mellitus, hypertension, dyslipidemia, chronic obstructive pulmonary disease (COPD), peripheral vascular disease (PVD), carotid stenosis, pre-operative myocardial infarction, renal dysfunction, EuroSCORE II, and left ventricular ejection fraction. Post-operative variables such as ventilation hours, stroke, renal failure, IABP usage, usage of inotropes, ICU stay, length of hospital stay, and mortality were included. Data was captured prospectively and analyzed using an electronic institutional database.

Operative risk is a potentially confounding variable in any analysis of POAF. To reduce its impact, we did a sub-analysis of patients with low operative risk (EuroSCORE II [\<]{.ul} 3).

Exclusion criteria {#FPar1}
------------------

CABG performed using cardiopulmonary bypass (25 patients) were excluded from the study. Patients with pre-operative AF were also excluded from the study.

Definition of variables {#FPar2}
-----------------------

POAF was defined by the Society of Thoracic Surgery (STS) definition---detection of AF or atrial flutter requiring treatment, prior to hospital discharge. Sepsis was defined as post-operative rise in temperature above 38.6 °C with white cell count \> 12,000 or \< 4000 with the need for starting empirical intra-venous antibiotics (STS definition). Usage of inotropes was defined as any requirement of inotropes or vasopressor in ICU. Pre-operative renal dysfunction was defined as creatinine clearance of less than 85 ml/min (EuroSCORE II criteria). Post-operative renal dysfunction was defined using the Acute Kidney Injury Network (AKIN) criteria \[[@CR18]\].

Ethical committee approval {#FPar3}
--------------------------

The study protocol was approved by the Institutional Ethical Committee (IRB-AIMS-2019-004). The need for informed consent was waived since the data used in this study had already been collected for the surgical database registry maintained by our Department of Cardiothoracic and vascular Surgery. All personal identifying data was removed from the study database so that individuals could not be identified.

OPCAB technique {#FPar4}
---------------

All patients underwent median sternotomy. Anterior fat pad was preserved in all patients. Heparin was administered to achieve a target-activated clotting time of more than 400 s. Left internal mammary artery was the preferred conduit to bypass left anterior descending artery. Saphenous vein grafts were the preferred conduit to bypass the other systems. Proximal anastomoses were constructed in ascending aorta using partial occlusion clamp. Posterior pericardiotomy was not performed in any of the patients. Heparin was fully reversed with protamine after the procedure. Patients were shifted to dedicated intensive care unit for post-operative monitoring.

Perioperative care {#FPar5}
------------------

Angiotensin-converting enzyme (ACE) inhibitors, β-blocker therapy, and aspirin were continued to the day of surgery. Clopidogrel was withdrawn 2 days prior to operation. β-Blocker was started on post-operative day 1, if the patients were not on inotropes and vasopressor agents. All patients received atorvastatin 20 mg on the first post-operative day. Hypokalemia below 3.5 mEq/L was corrected. Routine magnesium sulfate correction was not done in any patients. All patients were monitored with continuous cardiac output with pulmonary artery flotation catheter (Edward Lifesciences, USA). POAF was controlled by amiodarone infusion if hemodynamically stable. Hemodynamically unstable patients underwent cardio-version. Patients with recurrent POAF and persisting AF were anticoagulated by warfarin to a target international normalized ratio of 2.0, for 1 month. If the repeat electrocardiogram (ECG) showed normal sinus rhythm, anticoagulation was stopped. All patients not on warfarin were treated with dual antiplatelet therapy (aspirin 150 mg + clopidogrel 75 mg) for 1 year post-CABG; thereafter, only aspirin was prescribed.

Follow-up {#FPar6}
---------

All discharged-from-hospital patients were evaluated in our outpatient clinic at 30 days. Then, the patients were asked to follow-up at 3 months after surgery and then yearly. They were evaluated with chest X-ray and ECG. All patients with left ventricular (LV) ejection fraction [\<]{.ul} 35% underwent echocardiography evaluation at each follow-up. Patients who did not turn up for follow-up (124 patients) were contacted telephonically in February 2018. Twenty-four patients (3.2%) were lost to follow-up. Median follow-up period was 630 days. Data were captured prospectively and entered in to a database.

Statistical analysis {#FPar7}
--------------------

Analysis was performed using IBM SPSS 20.0 version (SPSS Inc., Chicago, USA). The continuous variables were presented using mean ± standard deviation (SD). The categorical variables were expressed using frequency and percentage. To test the statistical significance of the difference in percentages of categorical variables between the two groups (AF and NSR), the chi-square test was used. To test the statistical significance of the difference in the mean of continuous variables between the two groups, the independent sample *t* test was used. Multivariate analysis (binary logistic regression) was used to find the most significant variables. All the variables with *p* value \< 0.2 in the univariate analysis were included for multivariate analysis. Kaplan-Meier analysis was used to find the survival probability and comparison was done using log-rank test. A *p* value \< 0.05 was considered as statistically significant.

Results {#Sec4}
=======

99.2% of POAF developed in patients above the age of 50 years (*p* value of 0.002). In univariate analysis of pre-operative variables, increasing age (*p* value \< 0.001), emergency surgery (*p* value 0.001), pre-operative renal dysfunction (*p* value 0.008), pre-operative myocardial infarction (*p* value 0.012), low left ventricular ejection fraction (*p* value 0.001), IABP usage (*p* value \< 0.001), development of post-operative sepsis (*p* value \< 0.001), blood stream infection (*p* value \< 0.001), and EuroSCORE II value more than 3 (*p* value \< 0.001) were identified as risk factors for POAF. Multivariate analysis is given in Table [1](#Tab1){ref-type="table"}.Table 1Multivariate analysisVariablesWald*p* valueOR (95% of CI)Age  \< 5019.627\< 0.001\*\*1  50--602.6800.1025.45 (0.72--41.56)  60--705.3840.02\*10.79 (1.45--80.50)  ≥707.5060.006\*17.05 (2.24--129.73)Sepsis41.567\< 0.001\*\*5.32 (3.20--8.85)IABP used3.4090.0654.39 (0.91--21.08)Significant *p* value \< 0.05\* and \< 0.001\*\**OR* odds ratio, *CI* confidence interval, *IABP* intra-aortic balloon pump

The ventilator hours and inotropes usage were significantly higher in the POAF group with *p* value \< 0.001. The incidence of post-operative stroke and renal dysfunction was also higher in POAF patients. The length of ICU stay and hospital stay was significantly higher in the AF group (Table [2](#Tab2){ref-type="table"}). Thirty-day/in-house mortality rate was also highly significant in the POAF group (7.1% vs. 1.5%; *p* value \< 0.001) (Table [2](#Tab2){ref-type="table"}).Table 2Comparison of outcome variables with post-operative normal sinus rhythm and atrial fibrillationVariablesNSR (*n* (%))AF (*n* (%))Univariate analysis621 (%)127 (%)OR (95% of CI)*p* valueVentilation hours11.93 ± 14.11431.31 ± 75.4341.02 (1.01--1.03)\< 0.001\*\*Duration of inotropes1.50 ± 1.343.31 ± 3.771.56 (1.34--1.82)\< 0.001\*\*Post-op stroke(Y)5 (0.8)4 (3.1)4.01 (1.06--15.13)0.027\*Post-op renal dysfunction(Y)5 (0.8)4 (3.1)4.01 (1.06--15.13)0.027\*Length of ICU stay3.07 ± 1.906.15 ± 5.401.51 (1.34--1.69)\< 0.001\*\*Length of hospital stay10.81 ± 4.6015.8 ± 10.871.10 (1.07--1.13)\< 0.001\*\*30-day mortality  Alive612 (98.5)118 (92.9)5.19 (2.02--13.34)\<0.001\*\*  Dead9 (1.5)9 (7.1)Significant *p* value \< 0.05\* and \< 0.001\*\**n* number of patients, *NSR* normal sinus rhythm, *AF* atrial fibrillation, *post-op* post-operative, *ICU* intensive care unit, *OR* odds ratio, *CI* confidence interval

For the NSR group, 1-year survival was 97.3%, 2-year survival was 96.9%, and 3-year survival was 94.4%. For the POAF group, 1-year survival was 88.7% and 3-year survival was 81.3%. In overall survival analysis, the mean survival time of the NSR group was 1110.07 ± 8.13 days and the mean survival time of the POAF group was 997.62 ± 34.71 days which showed statistically significant difference in the survival probability with *p* value \< 0.001. The HR was 3.867 (1.99--7.52) (Fig. [1](#Fig1){ref-type="fig"} A, B). The mean survival time of the NSR group above 30 days was 1123.07 ± 6.58 and the mean survival time of the POAF above 30 days was 1075.15 ± 26.08 which showed statistically significant difference in the survival probability with *p* value \< 0.001. Eighteen (12 patients in the NSR group and 6 in the POAF group) patients expired during follow-up. In 2 patients (one in each group), the cause of death could not be ascertained. All patients in POAF and 8 patients in NSR died due to cardiac cause. The non-cardiac causes included COPD exacerbation in 2 patients, malignancy in one patient, and sepsis from cellulites in another patient. There was no difference in myocardial infarction rates, angina rates, repeat revascularization, and heart failure admissions between the 2 groups. However, late occurrence of chronic kidney disease and stroke was more common in the POAF group during follow-up (Table [3](#Tab3){ref-type="table"}).Fig. 1**A** and **B** Kaplan-Meir estimate of survival of patients in all patients; NSR vs. POAFTable 3Follow-upVariablesAlive (*n* = 706)NSR (*n* (%))AF (*n* (%))591 (%)115 (%)Revascularization10 (1.69)2 (1.74)Stroke3 (0.51)2 (1.74)Heart failure4 (0.68)0 (0)Renal dysfunction18 (3.05)8 (6.96)Renal failure requiring dialysis4 (0.68)0 (0)Myocardial infarction5 (0.85)0 (0)Angina11 (1.86)2 (1.74)Mid-term mortality12 (2.03)6 (5.23)*NSR* normal sinus rhythm, *AF* atrial fibrillation, *n* number of patients

In 748 patients, 529 patients in the NSR group and 92 patients in the AF group were low-risk patients (EuroSCORE II \< 3) included for a separate sub-analysis of this cohort. In the univariate analysis of low-risk patients, age (*p* value 0.001), pre-operative renal dysfunction (*p* value 0.016), development of post-operative sepsis (*p* value \< 0.001), and blood stream infections (BSI) (*p* value 0.004) were identified as risk factors for POAF. Multivariate analysis is given in Table [4](#Tab4){ref-type="table"}.Table 4Multivariate analysis in low-risk patientsVariablesWald*p* valueOR (95% of CI)IABP used4.760.029\*34.43 (1.43--826.90)Age  \< 5014.820.002\*1  50--602.700.1016.35 (0.70--57.64)  60--705.560.018\*13.96 (1.56--124.88)  ≥ 706.460.011\*18.24 (1.94--171.20)Sepsis26.06\< 0.001\*\*5.60 (2.89--10.86)Pre-op recent MI3.510.0610.62 (0.38--1.02)Pre-op renal dysfunction2.990.0840.47 (0.20--1.11)Significant *p* value \< 0.05\* and \< 0.001\*\**OR* odds ratio, *CI* confidence interval, *IABP* intra-aortic balloon pump, *pre-op* pre-operative, *MI* myocardial infarction

The ventilator hours and inotrope usage were highly significant in the POAF group with *p* value \< 0.001. Post-operative stroke showed significance in the POAF group with *p* value 0.036. The length of ICU stay and hospital stay was statistically highly significant in the POAF group with *p* value \< 0.001 (Table [5](#Tab5){ref-type="table"}). Thirty-day/in-house mortality rate was also highly significant in the POAF group (4.3% vs. 0.8%, HR 5.966; confidence interval (CI) 1.47--24.29, *p* value 0.005) (Table [5](#Tab5){ref-type="table"}).Table 5Comparison of outcome variables of low-risk patients (EuroSCORE II \< 3) with post-operative normal sinus rhythm and atrial fibrillationVariablesNSR (*n* (%))AF (*n* (%))Univariate analysis529 (%)92 (%)OR (95% of CI)*p* valueVentilation hours11.21 ± 13.5217.54 ± 23.371.02 (1.01--1.03) \*\< 0.001\*Duration of inotropes1.37 ± 1.272.61 ± 3.171.51 (1.23--1.84) \*\< 0.001\*Post-op stroke4 (0.8)3 (3.3)4.42 (0.97--20.10)0.036\*Post-op renal dysfunction2 (0.4)0 (0)00.555Length of ICU stay2.95 ± 1.895.32 ± 4.371.50 (1.30--1.74) \*\< 0.001\*Length of hospital stay10.54 ± 4.3413.81 ± 8.811.09 (1.05--1.13) \*\< 0.001\*30-day mortality  Alive525 (99.2)88 (95.7)5.97 (1.47--24.29)0.005\*  Dead4 (0.8)4 (4.3)Significant *p* value \< 0.05\* and \< 0.001\*\**n* number of patients, *NSR* normal sinus rhythm, *AF* atrial fibrillation, *post-op* post-operative, *ICU* intensive care unit, *OR* odds ratio, *CI* confidence interval

The stroke rate and incidence of renal dysfunction were higher during follow-up in the POAF group (Table [6](#Tab6){ref-type="table"}). The overall survival analysis was done in low-risk patients of the NSR and AF groups with mean survival time 1113.26 ± 7.85. For the NSR group, 1-year survival was 98% and 3-year survival was 95.7%. For the POAF group, 1-year survival was 94.4% and 3-year survival was 84.0%. The mean survival time of the NSR group was 1120.91 ± 7.42 days and the mean survival time of the POAF group was 1053.49 ± 34.38 days which showed statistically significant difference in the survival probability with *p* value 0.02. The hazard ratio was 3.79 (1.90--7.59) (Fig. [2 A](#Fig2){ref-type="fig"}, B).Table 6Follow-up of low-risk patientsVariablesAlive (*n* = 595)NSR (*n* (%))AF (*n* (%))509 (%)86 (%)Revascularization9 (1.77)2 (2.32)Stroke2 (0.39)2 (2.32)Heart failure2 (0.39)0 (0)Renal dysfunction11 (2.16)6 (6.98)Renal failure requiring dialysis3 (0.59)0 (0)Myocardial infarction5 (0.98)0 (0)Angina7 (1.37)2 (2.32)Mid-term mortality9 (1.77)2 (2.32)*NSR* normal sinus rhythm, *AF* atrial fibrillation, *n* number of patientsFig. 2**A** and **B** Kaplan-Meir estimate of survival of patients in low-risk group NSR vs. POAF

Of 118 patients in the POAF group discharged alive, 20 patients (16.9%) were in AF. Ninety-eight patients (83%) were on oral amiodarone. At 30 days, 14 patients (11.7%) were in AF. Persistent AF after 3 months was seen in 3 patients (2.5%). Cardio-version was attempted in all the three patients; one patient reverted to NSR. Remaining 2 patients remained in chronic AF; out of which, one patient expired after 31 months from severe LV dysfunction, renal failure, and urosepsis.

Discussion {#Sec5}
==========

The study showed that (1) the incidence of POAF was much lower than reported in western literature, (2) sicker patients have more propensities to develop AF, (3) the patients who developed POAF had much higher short-term mortality and morbidity, and (4) they had lower survival chance when compared with NSR patients in follow-up.

The incidence of POAF was 16.7% in this study. New onset of AF occurred in 24.9% of patients after CABG according to the latest STS data report \[[@CR19]\]. The role of OPCAB in reducing the incidence of AF is controversial. CPB inclusive of cardioplegic arrest was the main independent predictor of POAF (OR 7.4, CI 3.4--17.9) in patients undergoing CABG in a prospective randomized study reported by Ascione et.al \[[@CR7]\]. However, this report was criticized for its small patient sample size and single-center origin. Moreover, several studies failed to show statistical association between OPCAB and a lower incidence of POAF. Investigators of the ROOBY trial (the randomized on vs. off bypass trial) found that the incidence of POAF was 27% in off-pump group with no difference in POAF rate based on off-pump vs. on-pump strategy of revascularization \[[@CR20]\]. The ROOBY trial was criticized for the fact that the conversion rate to CPB was unacceptably high at 12% and has drawn skepticism as to the level of "off pump" experience of the surgeons involved in the study. Patients enrolled were almost exclusively males and there was a trend toward enrolling lower-risk patients and excluding higher-risk patients. It is questionable whether this study is applicable to the real world. In the mass III trial, the incidence of POAF in OPCAB patients was 35% and much higher than patients undergoing on-pump CABG \[[@CR21]\]. Since we rarely perform CABG using CPB, we are unable to comment on this outlier study.

The average age in our study was 62 years ± 10 which is lower than those reported from the western data \[[@CR19]\]. Moreover, in patients below the age of 50 years who underwent CABG (which formed 8.7% of our cohort), incidence of POAF was only 0.8%. In the recently published OPERA (omega-3 fatty acids for prevention of post-operative atrial fibrillation) trial \[[@CR22]\], compared with on-pump CABG, OPCAB was significantly associated with a lower risk of POAF (odds ratio (OR), 0.53; 95% CI, 0.33--0.85) among men and in patients aged less than 65 years (OR, 0.35; 95%CI, 0.16--0.75). Lower POAF rates are reported in the south Asian population \[[@CR9], [@CR10]\] compared with the Caucasian race. Younger age at the time of revascularization and lower body mass index are the usual reasons for the lower incidence of POAF in the south Asian population \[[@CR23]\]. Further, data from the Asian continent is not as widely reported in the global literature for want of systemic data collection and reportage. Owing to the purported differences of race as seen above, it is likely that the outcomes from Asia will differ from those reported in the North American and European continents.

Advanced age is associated with degenerative and inflammatory modifications in atrial anatomy (dilation, fibrosis), which alters electrophysiological properties of atria, namely, shortness of effective refractory period, dispersion of refractoriness and conduction, abnormal automaticity, and anisotropic conduction, which predisposes to development of AF \[[@CR10]\]. One study showed that \[[@CR10]\] for every 10-year increase in age, there was a 75% increase in the chance for developing AF. We also found significant increase in POAF occurrence with each passing decade after 50 years: 1.8% in patients \< 50 years, 10.79% in 50--59 years, 19.25% in 60--69 years, 28.22% in 70--79 years, and 50% in patients above the age of 80 years.

Sepsis after OPCAB is thought to be less due to avoidance of the inflammatory response of CPB. However, surgical stresses, blood transfusions, and endotoxemia from bacterial translocation from gut are some factors that provoke the development of systemic inflammatory syndrome/sepsis in OPCAB \[[@CR24]\]. In our series, 11.2% of patients developed clinical and or laboratory features suggestive of sepsis. 2.67% had positive bacterial cultures. It is also likely that secondary to multiple systemic issues in healthcare, the burden of nosocomial sepsis, including post-operative sepsis, is higher in emerging economies. In multivariate analysis, it has emerged as a strong risk factor for development of POAF. Systemic inflammation associated with sepsis is a well-known trigger for development of POAF in critically ill patients \[[@CR25]\]. This study highlights the important contribution of sepsis to the occurrence of POAF, hitherto probably under reported in the post-operative cardiac surgical population. POAF will worsen the hemodynamic parameters in patients with both diastolic dysfunction \[[@CR26]\] and systolic dysfunction emphasizing needs for the health systems in these countries to target sepsis control as high priority. All these factors potentially lead to prolonged ICU stay with increased mortality.

Ventilator hours, length of ICU stay, and length of hospital stay were increased in POAF patients. ICU stay was increased by 1.5 days and hospital stay by 1 day and ventilator hours by 20 h in POAF patients. Stroke is a devastating complication after cardiac surgery. The stroke rate was 3.1% in patients developing POAF compared with 0.8% in NSR (fourfold increase in POAF). Moreover, there was a tendency for increased stroke rate on follow-up in POAF patients. POAF is a well-known cause of late recurrence of AF with potential hazard for stroke. These results were independent of the risk profile of patients.

In our study, there was a fivefold increase in 30-day mortality in patients with POAF. This trend of decreased survival continued in the follow-up period. It is still not clear in existing literature whether the increased risk for mortality in POAF patients is due to the effect of AF or whether AF is only a surrogate marker for severity of illness \[[@CR27]--[@CR31]\]. Further, the independent contribution of POAF to these greatly increased risks is unknown as sepsis, in itself, can hugely impair post-operative outcome. The analysis of the impact of POAF in the low-risk cohort underlines the need for emphasizing its impact on overall outcomes, and, in turn, to develop a strategy for prevention as a key quality improvement measure.

Study limitations {#Sec6}
=================

This is a single-center study. We examined only 12 pre-operative variables for risk analysis. Therefore, other predictors associated with POAF could have been excluded. Continuous ECG monitoring of patients occurred only during ICU stay. More systematic ECG monitoring could result in a better identification and a higher detected incidence of AF. We also do not have any data regarding occurrence of late AF. It is clinically difficult to separate sepsis due to infection and systemic inflammatory response. Hence, we used the STS definition to document sepsis. The patients in the medium- and high-risk categories (EuroSCORE \> 3 and 6 respectively) were small in number in the overall POAF cohort, limiting analysis for these patients. The study however is likely the first study with complete immediate follow-up and 97% follow-up over the midterm (follow-up of 2 years) from the Indian subcontinent. The report will hopefully spurn multicenter initiatives to map surgical outcomes and collaborative preventive and quality improvement measures.

Conclusion {#Sec7}
==========

POAF remains a common complication after CABG; however, the incidence seemed to be lower than reported in western literature. Increasing age and development of post-operative sepsis were strong independent predictors of POAF. The standard measurable outcomes like mortality, stroke, and renal failure requiring dialysis, ventilator hours, length of ICU stay, and length of hospital stay were increased in patients developing POAF. However, sepsis remains a confounding variable and may be the trigger for development of POAF and the increase in adverse events. There should be a renewed interest in developing effective preventive strategies for the occurrence of POAF. Those patients who develop POAF should be followed up meticulously to reduce complications and improve the survival in the long term.
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